The purpose of the National Ovarian Cancer Audit (NOCA) is to evaluate the patterns of care and outcomes for patients with ovarian cancer in England and Wales, and to support services to improve the quality of care for these patients.
NOCA is part of the National Cancer Audit Collaborating Centre (NATCAN), the home of the ten national cancer audits in England and Wales. This national centre of excellence was established to strengthen cancer services by evaluating the process of diagnosis and treatment, and patient outcomes in multiple cancer sites.
This version includes the fourth quarterly clinical performance indicator report produced by the NOCA, which has been released alongside an updated version of their data quality dashboard.
The quarterly report provides an overview of the performance indicators as well as quality of key data items from Rapid Cancer Registration Data (RCRD). The main cohort comprises a definition of ovarian cancer using RCRD supplied by the National Disease Registration Service (NDRS) for ICD10 codes C56 ovarian cancer, C57 fallopian tube cancer, C48 primary peritoneal cancer after excluding sarcomas, and D39.1 cancer of the ovary of uncertain or unknown behaviour.
Further information about the RCRD can be found here.
This NOCA report allocates patients to NHS organisations based on the “trust at diagnosis” recorded within the RCRD dataset.
Please note: the total number of patients from which the Cancer Alliance and NHS trust figures were derived is less than the total number of patients used for the national figures. This is because not all patients had a trust of diagnosis in the RCRD data.
Contact details
For any queries relating to the audit
- Email:
- [email protected]